Myelofibrosis other diagnostic studies

Myelofibrosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myelofibrosis other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myelofibrosis other diagnostic studies All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myelofibrosis other diagnostic studies
CDC on Myelofibrosis other diagnostic studies
Myelofibrosis other diagnostic studies in the news
Blogs on Myelofibrosis other diagnostic studies
Directions to Hospitals Treating Myelofibrosis
Risk calculators and risk factors for Myelofibrosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Other Diagnostic Studies

JAK2 Mutation Analysis Testing

• Reverse transcriptase polymerase chain reaction (RT-PCR) may be performed to observe the JAK2 mutation.
• JAK2 mutation on Val 617 Phe locus in 50%

References

Template:WikiDoc Sources